These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 29373922

  • 21. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Lakshmanan AP, Watanabe K, Thandavarayan RA, Sari FR, Harima M, Giridharan VV, Soetikno V, Kodama M, Aizawa Y.
    Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
    [Abstract] [Full Text] [Related]

  • 22. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.
    Yang G, Zhao Y, Zhang Y, Dang B, Liu Y, Feng N.
    Int J Nanomedicine; 2015 May; 10():6633-44. PubMed ID: 26543366
    [Abstract] [Full Text] [Related]

  • 23. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR, Kasala ER, Bodduluru LN, Mahareddy JR, Uppulapu SK, Gogoi R, Barua CC, Lahkar M.
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A, El-Moselhy MA, Taye A, Khalifa MM.
    Eur J Pharmacol; 2014 Dec 05; 744():173-82. PubMed ID: 25446917
    [Abstract] [Full Text] [Related]

  • 25. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA, El-Sayad ME, El-Kadem AH.
    Biomed Pharmacother; 2016 Jul 05; 81():136-144. PubMed ID: 27261587
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study.
    Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S.
    J Int Med Res; 2005 Jul 05; 33(6):677-86. PubMed ID: 16372586
    [Abstract] [Full Text] [Related]

  • 28. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK, Reddy K, Balakumar P.
    Eur J Pharmacol; 2010 Jun 25; 636(1-3):137-44. PubMed ID: 20347778
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
    Arafat M, Kirchhoefer C, Mikov M, Sarfraz M, Löbenberg R.
    J Pharm Pharm Sci; 2017 Jun 25; 20(0):305-318. PubMed ID: 28885915
    [Abstract] [Full Text] [Related]

  • 31. The effects of grape seed on apoptosis-related gene expression and oxidative stress in streptozotocin-induced diabetic rats.
    Güçlü A, Yonguç N, Dodurga Y, Gündoğdu G, Güçlü Z, Yonguç T, Adıgüzel E, Turkmen K.
    Ren Fail; 2015 Mar 25; 37(2):192-7. PubMed ID: 25565258
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress.
    Deng X, Cheng J, Shen M.
    J Endocrinol Invest; 2016 Jun 25; 39(6):657-66. PubMed ID: 26691308
    [Abstract] [Full Text] [Related]

  • 34. Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammation.
    Olatunji OJ, Chen H, Zhou Y.
    Biomed Pharmacother; 2018 Jun 25; 102():1145-1151. PubMed ID: 29710532
    [Abstract] [Full Text] [Related]

  • 35. Renoprotective effects of telmisartan in the 5/6 nephrectomised rats.
    Tsunenari I, Ohmura T, Seidler R, Chachin M, Hayashi T, Konomi A, Matsumaru T, Sumida T, Hayashi N, Horie Y.
    J Renin Angiotensin Aldosterone Syst; 2007 Jun 25; 8(2):93-100. PubMed ID: 17703436
    [Abstract] [Full Text] [Related]

  • 36. The effects of bile salt hydrophobicity on model bile vesicle morphology.
    van de Heijning BJ, Stolk MF, van Erpecum KJ, Renooij W, van Berge Henegouwen GP.
    Biochim Biophys Acta; 1994 May 13; 1212(2):203-10. PubMed ID: 8180246
    [Abstract] [Full Text] [Related]

  • 37. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.
    Al-Rasheed NM, Al-Rasheed NM, Bassiouni YA, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mahmoud AM.
    Biomed Pharmacother; 2018 Sep 13; 105():290-298. PubMed ID: 29860221
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB.
    Lee WC, Chen HC, Wang CY, Lin PY, Ou TT, Chen CC, Wen MC, Wang J, Lee HJ.
    Biosci Biotechnol Biochem; 2010 Sep 13; 74(7):1355-61. PubMed ID: 20622454
    [Abstract] [Full Text] [Related]

  • 40. Glycine mitigates renal oxidative stress by suppressing Nox4 expression in rats with streptozotocin-induced diabetes.
    Wang Z, Zhang J, Wang L, Li W, Chen L, Li J, Zhao D, Zhang H, Guo X.
    J Pharmacol Sci; 2018 Aug 13; 137(4):387-394. PubMed ID: 30196019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.